In searching for prognostic markers in transcatheter aortic valve replacement: Diastolic dysfunction and insulin-like growth factor system assessment-Reference-Cited by-同舟云学术

In searching for prognostic markers in transcatheter aortic valve replacement: Diastolic dysfunction and insulin-like growth factor system assessment

Published:2019-08 Issue: Volume:288 Page:63
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Tzanis Georgios,Philippou Anastassios,Biliou Smaragda,Giannini Francesco,Koutsilieris Michael,Nanas Serafim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI);Muessig;Int. J. Cardiol.,2018

2. The impact of left ventricular diastolic dysfunction on clinical outcomes after transcatheter aortic valve replacement;Asami;J. Am. Coll. Cardiol. Intv.,2018

3. Comparison of prognostic usefulness of serum insulin-like growth factor-binding protein 7 in patients with heart failure and preserved versus reduced left ventricular ejection fraction;Hage;Am. J. Cardiol.,2018

4. Insulin-like growth factor-binding protein 7 as a biomarker of diastolic dysfunction and functional capacity in heart failure with preserved ejection fraction: results from the RELAX trial;Gandhi,2016

5. Insulin-like growth factor-1 bioregulation system abnormalities: another explanatory mechanism of exercise intolerance in heart failure;Tzanis;JACC Heart Fail.,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to: In searching for prognostic markers in transcatheter aortic valve replacement: Diastolic dysfunction and insulin-like growth factor system assessment;International Journal of Cardiology;2020-05